Enhanced TAU | Outcome in TAU | |||||
---|---|---|---|---|---|---|
Randomized Controlled Trial | Years in the study | No of personal examinations | Additional therapeutic activity | Reduction of psychological symptoms | Survival rate (%) at end of study | Estimated survival rate within 8 years1 |
RCPP [19] | 4.5 y. | 5 (3 cardiologic, 2 psycho logical) | 33 group sessions à 90 min. | Type A behaviour: −9.8%; ES2: 0.72; 95%CI 0.89–0.56 | 92.8% | 87.2 |
Jones and West [20] | 1 y. | 3 | 0 | depression not specified for TAU | 92.8% | 42.4%1 |
M-HEART [21] | 1 y. | 3 (1 cardiological, 3 psychological) | 0 | BDI depression: - 9.5%; ES2: 0.1; 95%CI 0.26–0.07 | 94.6% | 56.8%1 |
ENRICHD [22] | 2.4 y. | 5 (cardiolog.,psychological) | Active partnership Health booklet | BDI depression: −33%; ES2: 0.69; 95%CI 0.85–0.53 | 86.2%. | 54.3% |
CREATE [23] | 0.25 y | 2 (cardiolog.,psychological) | 12 × 20 min clinical management | BDI: − 40.3% HAMD:-48%; ES2: 1.81; 95%CI 2.2–1.42 | 100% / | ? |
SWICHD [24] | 7.1 y. | 1(cardiolog, psychological; 2x questionnaires by letter) | 0 | depressive symptoms: −16.1%; ES3: 0.25; 95%CI 0.64–0.14 | 80.1% / | 77.6% |
SUPRIM [25] | 7.8 y. | 5 (cardiological, psychological) | 0 | Depression not reported | 85.2% / | 84.8% |
SPIRR-CAD [26] | 2 y. | 5 (2x cardiologic, 5x psychological) | 30 min information on risk factors | HADS-D − 13.4%; ES4:0.41 95%CI 0.65–0.18 remission on HADS-D 35.8% | 96.8% / | 87.2% |